MIDATECH PHARMA
News | News 2015
Dec 30, 2015
Midatech completes acquisition of Zuplenz®

~ Further product acquisition bolsters marketed oncology portfolio ~

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the... read more >

Dec 18, 2015
Midatech agrees to acquire marketed oncology product, Zuplenz®, from Galena Biopharma, Inc.

~Zuplenz® (ondansetron) oral soluble film prevents post-operative, chemotherapy- and radiation-induced nausea and vomiting~

... read more >
Dec 14, 2015
Midatech signs supply agreement with Centurion Pharma

~ Q-Octreotide license agreement in Turkey further expands the international and commercial outlook of Midatech ~

... read more >
Oct 27, 2015
Midatech selects Fujitsu to provide IT solutions

Midatech Pharma (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in... read more >

Aug 13, 2015
Ocular Agreement with Ophthotech

- Development of sustained delivery formulations for rapidly growing ophthalmology market
- Underpins Midatech’s financial guidance for... read more >

Jul 20, 2015
Initiation of Phase IIa study of insulin delivery via buccal strip for type 1 diabetes

Midatech (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in... read more >

Apr 14, 2015
Research Collaboration Signed with National Cancer Center for Targeted Nanomedicines against Glioblastoma

Midatech Pharma (AIM: MTPH), the international specialty pharmaceutical with a diversified portfolio of high-value assets,... read more >

Feb 18, 2015
Midatech Pharma Appoints Katharine Andrews as Head of Regulatory Affairs

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Feb 9, 2015
Midatech Pharma Wins Innovation & Excellence in Healthcare Award

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Jan 20, 2015
Midatech Biogune completes the refit to adapt to aseptic manufacture

This month Midatech Biogune S.L., part of the Midatech Pharma group, has completed the refit of its plant in Bilbao. The aim was to adapt the... read more >

 

News
News 2015
Dec 30, 2015
Midatech completes acquisition of Zuplenz®

~ Further product acquisition bolsters marketed oncology portfolio ~

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the... read more >

Dec 18, 2015
Midatech agrees to acquire marketed oncology product, Zuplenz®, from Galena Biopharma, Inc.

~Zuplenz® (ondansetron) oral soluble film prevents post-operative, chemotherapy- and radiation-induced nausea and vomiting~

... read more >
Dec 14, 2015
Midatech signs supply agreement with Centurion Pharma

~ Q-Octreotide license agreement in Turkey further expands the international and commercial outlook of Midatech ~

... read more >
Oct 27, 2015
Midatech selects Fujitsu to provide IT solutions

Midatech Pharma (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in... read more >

Aug 13, 2015
Ocular Agreement with Ophthotech

- Development of sustained delivery formulations for rapidly growing ophthalmology market
- Underpins Midatech’s financial guidance for... read more >

Jul 20, 2015
Initiation of Phase IIa study of insulin delivery via buccal strip for type 1 diabetes

Midatech (AIM: MTPH), the international specialty pharmaceutical company with a diversified portfolio of high-value products in... read more >

Apr 14, 2015
Research Collaboration Signed with National Cancer Center for Targeted Nanomedicines against Glioblastoma

Midatech Pharma (AIM: MTPH), the international specialty pharmaceutical with a diversified portfolio of high-value assets,... read more >

Feb 18, 2015
Midatech Pharma Appoints Katharine Andrews as Head of Regulatory Affairs

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Feb 9, 2015
Midatech Pharma Wins Innovation & Excellence in Healthcare Award

Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic products to enhance the... read more >

Jan 20, 2015
Midatech Biogune completes the refit to adapt to aseptic manufacture

This month Midatech Biogune S.L., part of the Midatech Pharma group, has completed the refit of its plant in Bilbao. The aim was to adapt the... read more >

© Copyright 2017 Midatech Pharma PLC